Biophysical Reviews, published by SpringerNature, is a leading international journal focused on the interdisciplinary areas of biophysics, structural biology, and molecular biology. With an impressive 2023 impact factor, the journal ranks in the Q1 category for biophysics and is also highly regarded in structural and molecular biology, reflecting its commitment to advancing understanding in these critical fields. Operating since 2009 and converging toward its goal of comprehensive coverage by 2024, Biophysical Reviews provides a platform for researchers to share innovative insights and critical reviews that shape the future of biophysical sciences. Its rigorous peer-review process ensures high-quality publications that are closely monitored within the academic community, making it an essential resource for researchers, professionals, and students aiming to stay at the forefront of biophysical research. Access options are available for enhancing the dissemination of knowledge, supporting a broad audience dedicated to scientific excellence.

FEBS Open Bio is a leading open-access journal published by Wiley, dedicated to advancing our understanding of biochemistry, genetics, and molecular biology. Since its inception in 2011, this journal has provided a robust platform for researchers to share their findings with a wider audience, ensuring the dissemination of high-quality scientific knowledge. With an impact factor reflecting its stature in its field, FEBS Open Bio is ranked #77 out of 221 in general biochemistry, genetics, and molecular biology, placing it in the 65th percentile among its peers. This journal serves as an essential resource for professionals, researchers, and students alike, fostering collaboration and innovation within the scientific community. The commitment to open access not only enhances visibility but also promotes transparency in research, making it a vital contributor to the ongoing dialogue in biochemical and molecular biological sciences. For those looking to stay at the forefront of research developments, FEBS Open Bio is a key publication addressing the latest trends and discoveries in the field.

ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.

COMPUTATIONAL BIOLOGY AND CHEMISTRY is a distinguished academic journal published by Elsevier Science Ltd, focusing on the dynamic intersection of computational biology, biochemistry, and chemistry. With an ISSN of 1476-9271 and an E-ISSN of 1476-928X, this journal is committed to disseminating high-quality research that employs computational techniques to solve complex biological and chemical problems. As of 2023, the journal holds a substantial impact factor reflecting its significance and rigorous peer-review process, categorized in the Q2 quartile for both Computational Mathematics and Organic Chemistry, alongside Q3 classifications in Biochemistry and Structural Biology. With a continuous publication history spanning from 2003 to 2024, it serves as a critical resource for researchers, professionals, and students alike. The journal offers various open access options, ensuring that vital research findings are accessible to a global audience, further enhancing collaboration across disciplines. Engage with cutting-edge studies and contribute to the evolving landscape of computational methodologies in the life sciences through this esteemed publication.

Frontiers in Bioinformatics is a leading academic journal dedicated to advancing the field of bioinformatics by publishing high-quality research and review articles. Published by FRONTIERS MEDIA SA, this open-access journal aims to foster innovative research, promote collaborative initiatives, and provide a platform for the dissemination of findings related to computational biology, biostatistics, and the intersection of bioinformatics with other biological disciplines. With a focus on promoting accessibility and visibility of research, Frontiers in Bioinformatics operates under a rigorous peer-review process, ensuring that all published content meets the highest academic standards. The journal has shown a commendable rank across various Scopus categories, including Mathematics, Computational Mathematics, and multiple dimensions of Biochemistry and Molecular Biology, indicating its relevance and impact within the research community. Researchers, professionals, and students will find this journal invaluable for staying abreast of the latest developments and breakthroughs in bioinformatics, enhancing their studies and professional projects.

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

Acta Crystallographica Section D - Structural Biology is a premier academic journal published by the International Union of Crystallography, dedicated to advancing the field of structural biology. With an ISSN and E-ISSN of 2059-7983, this journal plays a crucial role in disseminating high-quality research, covering a wide spectrum of topics including crystallography, macromolecular structures, and their biological implications. Operating under a Q2 category ranking in the realm of structural biology, it highlights innovative and transformative studies that enhance our understanding of molecular architecture. The journal is notably indexed in Scopus, where it holds a rank of #28/49 in its category, placing it in the 43rd percentile. This robust positioning underscores its significance to the research community. With a reader base that includes leading scientists, professionals, and students in the biosciences, Acta Crystallographica Section D is integral for those looking to stay updated on cutting-edge discoveries in structural biology. The journal is available for readership and serves as a pivotal platform for researchers aiming to share their findings and contribute to the scientific dialogue.

Doklady Biochemistry and Biophysics is a vital resource for the advancement of knowledge in the fields of biochemistry and biophysics, published by MAIK NAUKA/INTERPERIODICA/SPRINGER. Featuring an ISSN of 1607-6729 and an E-ISSN of 1608-3091, this journal plays a critical role in disseminating research findings and fostering scholarly discourse. Despite its recent ranking in the Q4 quartile for biochemistry and biophysics in 2023, it serves as an essential platform for researchers exploring these intertwined disciplines. The journal’s scope encompasses a wide variety of topics, enhancing the understanding of biochemical processes and physical principles in biological systems. With converged years of publication from 2001 to 2024, it stands as a continual source of knowledge for its readers, who include researchers, professionals, and students alike. While the journal currently does not offer open access options, its contributions remain significant within the scholarly community, illustrated by its competitive Scopus rankings across related fields.

The Journal of Molecular Biology (ISSN: 0022-2836, E-ISSN: 1089-8638), published by Academic Press Ltd - Elsevier Science Ltd, stands as a premier platform for disseminating significant advancements in the field of molecular biology. With a distinguished history of publication spanning from 1959 to 2024, this journal is recognized for its high-quality, peer-reviewed articles that engage with transformative research in biophysics, structural biology, and molecular biology. The journal holds an impressive Q1 category ranking across these disciplines in 2023, affirming its impact and relevance within the scientific community. Notably, it ranks #11 in biophysics and #5 in structural biology based on Scopus metrics, placing it in the 93rd and 90th percentiles, respectively. As an essential resource for researchers, professionals, and students alike, the Journal of Molecular Biology serves as a vital conduit for the exchange of innovative ideas and discoveries, fostering a deeper understanding of life's molecular underpinnings.

Quarterly Reviews of Biophysics, published by Cambridge University Press, is a premier academic journal dedicated to the field of biophysics. With an impressive impact factor reflecting its esteemed reputation, this journal occupies a distinguished position as evidenced by its Q1 category ranking in Biophysics and its ranking of #7 out of 152 in the Scopus database, placing it in the top 5% of its field. The journal has been a significant contributor to the scientific community since its inception in 1968, offering insightful reviews and analysis that bridge the disciplines of biochemistry, genetics, and molecular biology. Quarterly Reviews of Biophysics provides an invaluable platform for researchers, professionals, and students alike to access high-quality, peer-reviewed content that enhances understanding of molecular interactions and systems biology. While Open Access is not currently offered, the journal remains committed to disseminating critical knowledge to advance research and innovation in biophysics.